AC:EURONEXT PARISAccor SA Analysis
Data as of 2026-06-22 - not real-time
$127.98
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Accenture plc is trading at $127.98, which is dramatically below its DCF‑derived fair value of $334.67, implying roughly a 54% upside potential. The stock’s price‑to‑earnings multiple of 10.2 is well under the industry average of 38.1, underscoring a deep valuation gap. A dividend yield of 5.09% with a payout ratio just above 50% is supported by robust free cash flow of $12.1 bn and a solid cash‑to‑debt ratio. Technical indicators show the shares are in oversold territory (RSI 20.9) and below all major moving averages (20‑day SMA $173.2, 50‑day SMA $177.8, 200‑day SMA $226.1), with the MACD line remaining bearish (-7.57) and a support level near $125.6. Volatility is elevated at 74% over the past 30 days, though beta is modest at 0.57, suggesting market‑wide swings rather than company‑specific risk.
Strategically, Accenture’s collaborations with AI leaders such as OpenAI, Microsoft, and AWS position it to capture growth in high‑margin digital transformation services, while its diversified global footprint and strong operating cash flow provide resilience. The combination of a substantial valuation upside, attractive dividend, and strategic growth levers makes the stock a compelling value‑oriented buy across horizons.
Strategically, Accenture’s collaborations with AI leaders such as OpenAI, Microsoft, and AWS position it to capture growth in high‑margin digital transformation services, while its diversified global footprint and strong operating cash flow provide resilience. The combination of a substantial valuation upside, attractive dividend, and strategic growth levers makes the stock a compelling value‑oriented buy across horizons.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- RSI indicates oversold conditions
- Proximity to support level at $125.6
- High dividend yield provides immediate income
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Large valuation gap versus DCF fair value
- Strong free cash flow and low debt-to-equity
- Strategic AI partnerships driving future growth
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustainable dividend supported by cash generation
- Robust client base across multiple geographies
- Continued exposure to high‑margin digital and cloud services
Key Metrics & Analysis
Financial Health
Revenue Growth5.60%
Profit Margin10.66%
P/E Ratio10.2
ROE24.41%
ROA10.90%
Debt/Equity25.04
P/B Ratio2.5
Op. Cash Flow$13.2B
Free Cash Flow$12.1B
Industry P/E38.1
Technical Analysis
TrendBearish
RSI20.9
Support$125.60
Resistance$198.00
MA 20$173.22
MA 50$177.80
MA 200$226.11
MACDBearish
VolumeIncreasing
Fear & Greed Index90.27
Valuation
Fair Value$334.67
Target Price$197.65
Upside/Downside54.44%
GradeUndervalued
TypeValue
Dividend Yield5.09%
Risk Assessment
Beta0.57
Volatility74.37%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.